Search Results - "Japiassu, A"

Refine Results
  1. 1
  2. 2

    Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care by Ramos, G. V., Guaraldo, L., Japiassú, A. M., Bozza, F. A.

    “…Summary What is known and objective Adverse drug events (ADE), common and underestimated in ICU patients, have direct consequences on length of stay, mortality…”
    Get full text
    Journal Article
  3. 3

    Short‐ and medium‐term prognosis of HIV‐infected patients receiving intensive care: a Brazilian multicentre prospective cohort study by Andrade, HB, da Silva, IRF, Ramos, GV, Medeiros, DM, Ho, YL, Carvalho, FB, Bozza, FA, Japiassú, AM

    Published in HIV medicine (01-11-2020)
    “…Objectives The characteristics of critically ill HIV‐positive patients and the causes of their admission to intensive care units (ICUs) are only known through…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Outcomes and resource use in Brazilian ICUs: results from the ORCHESTRA study by Soares, M, Angus, DC, Salluh, JI, Cavalcanti, AB, Colombari, F, Costa, R, Silva, E, Japiassu, A, Kahn, JM, Bozza, FA

    Published in Critical care (London, England) (01-01-2015)
    “…Methods A retrospective cohort study in 59,483 patients (medical admissions: 39,734 (67%)) admitted to 78 ICUs (private hospitals, n = 67 (86%); medical or…”
    Get full text
    Journal Article
  9. 9

    Revisiting steroid treatment for septic shock: molecular actions and clinical effects - a review by Japiassú, André M, Salluh, Jorge IF, Bozza, Patrícia T, Bozza, Fernando A, Castro-Faria-Neto, Hugo C

    Published in Memórias do Instituto Oswaldo Cruz (01-07-2009)
    “…Corticosteroids are widely used to treat a diversity of pathological conditions including allergic, autoimmune and some infectious diseases. These drugs have…”
    Get full text
    Journal Article
  10. 10

    ALTERAÇÕES HEMATOLÓGICAS E GRUPOS SANGUÍNEOS ABO: EXPLORANDO SUA INTERSECÇÃO EM PACIENTES COM COVID LONGO by CALCE Souza, R Martins-Gonçalves, MPD Ribeiro, K Geraldo, JB Felix, J Bokel, MSS Dias, ILM Alves, BEA Rendón, MD Ibarrola, RE Almeida, AM Japiassú, P Azambuja, SW Cardoso, PT Bozza, VG Veloso, B Grinsztejn, AG Vizzoni, DPM Almeida

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…A COVID longa é caracterizada pela persistência de sintomas após a fase aguda da infecção por SARS-CoV-2. Embora a etiologia dos sintomas permaneça…”
    Get full text
    Journal Article
  11. 11

    AVALIAÇÃO VASCULAR DE MEMBROS INFERIORES EM PACIENTES COM COVID-19 LONGO by BEA Rendón, CALCE Souza, ILM Alves, R Martins-Gonçalves, J Bokel, MSS Dias, K Geraldo, JB Felix, MPD Ribeiro, RE Almeida, AG Vizzoni, P Azambuja, SW Cardoso, PT Bozza, VG Veloso, B Grinsztejn, AM Japiassú, DPM Almeida

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…A síndrome pós-COVID-19 é definida por sintomas persistentes e/ou complicações tardias pelo vírus SARS-CoV2 após 90 dias da infecção aguda. É uma importante…”
    Get full text
    Journal Article
  12. 12

    ACOMPANHAMENTO CLÍNICO E PERFIL VACINAL DE UMA COORTE DE PACIENTES COM COVID LONGO by ILM Alves, CALCE Souza, BEA Rendón, R Martins-Gonçalves, J Bokel, MSS Dias, MD Ibarrola, MPD Ribeiro, K Geraldo, JB Felix, RE Almeida, AG Vizzoni, P Azambuja, SW Cardoso, PT Bozza, VG Veloso, B Grinsztejn, AM Japiassú, DPM Almeida

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…A síndrome pós-COVID-19 é definida por sintomas persistentes e/ou complicações tardias pelo vírus SARS-CoV2 após 4 semanas do início dos sintomas. A…”
    Get full text
    Journal Article
  13. 13

    POSITIVIDADE PARA ANTICORPOS ANTIFOSFOLIPÍDEOS EM PACIENTES COM COVID LONGO by DPM Almeida, CALCE Souza, R Martins-Gonçalves, MPD Ribeiro, AG Vizzoni, J Bokel, MSS Dias, ILM Alves, BEA Rendón, MD Ibarrola, RE Almeida, AM Japiassú, K Geraldo, JB Felix, P Azambuja, SW Cardoso, PT Bozza, VG Veloso, B Grinsztejn

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Os sintomas associados ao COVID podem permanecer por longos períodos e impactar a vida de muitos pacientes e familiares. Os anticorpos antifosfolípides (aPL)…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis by BOZZA, Fernando A, GOMES, Rachel N, JAPIASSU, André M, SOARES, Marcio, CASTRO-FARIA-NETO, Hugo C, BOZZA, Patricia T, BOZZA, Marcelo T

    Published in Shock (Augusta, Ga.) (01-10-2004)
    “…Macrophage migration inhibitory factor (MIF) is a cytokine playing a critical role in the pathophysiology of experimental sepsis. The purpose of this study was…”
    Get full text
    Journal Article
  16. 16
  17. 17

    O direito penal internacional e os crimes internacionais by Carlos Eduardo A. Japiassú

    Published in Revista Interdisciplinar de Direito (01-12-2012)
    “…Desde a Antiguidade, podem ser encontradas manifestações daquilo que se convencionou chamar de direito penal internacional. Todavia, o seu efetivo…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20